People

Grant  H.  Skrepnek , Ph.D., R.Ph.

Associate Professor

Department of Pharmacy: Clinical and Administrative Sciences

Phone (405) 271-6878  xext. 47105
Fax (405) 271-6430
Office   CPB 214
Email grant-skrepnek@ouhsc.edu

Research Summary

Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek foxes on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardio-pulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.

Education & Experience

Education

The University of Texas at Austin (2002). Major: Pharmacy Administration, Doctor of Philosophy Curriculum; Minors: Finance, Management. Dissertation: Stock market valuation and firm-level determinants of innovative activity in the pharmaceutical industry.

The University of Texas at Austin (1998). Major: Pharmacy Administration, Master of Science Curriculum. Thesis: The effect of merger and acquisition activity on shareholder returns in the pharmaceutical industry.

The University of Texas at Austin (1994). Major: Pharmacy, Bachelor of Science Curriculum. Career Track: Pharmacy Business Management.

Employment History

    Associate Professor, Dept. of Pharmacy: Clinical and Administrative Sciences, OU College of Pharmacy. July 2013-present.

    Associate Professor with Tenure, Dept. of Pharmaceutical Sciences; Dept. of Pharmacy Practice & Science, University of Arizona College of Pharmacy 2008-2013.

    Assistant Professor, Dept. of Pharmaceutical Sciences; Dept. of Pharmacy Practice & Science, University of Arizona College of Pharmacy 2002-2008.

view full profile

Selected Publications & Presentations

  1. Johnson P N, Skrepnek G H, Golding C C, Owora A H, Miller T N, Miller J L. Impact on fentanyl continuous infusion rate on time to sedation among non-obese and obese critically-ill children American Journal of Health-System Pharmacists. In Press;
  2. Scalese M J, Herring H H, Rathbun C, Skrepnek G H, Ripley T L. Propofol-associated QTc prolongation Therapeutic Advances in Drug Safety. 2016;
  3. Liedtke M D, Tomlin C R, Skrepnek G H, Farmer K, Johnson P N, Rathbun C. HIV pharmacist's impact on inpatient antiretroviral errors HIV Med. 2016;
  4. Keast S, Nesser N, Skrepnek G H. State Medicaids bring managed care tenets to fee-for-service. JMCP. 2016;
  5. Skrepnek G H. Health Economic and Outcomes Research in Cancer [chapter] Springer. 2015;
  6. show more